Biotest Divestiture Trust → ADMA BIOLOGICS, INC. ADMA

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 9.12

24,031,512 shares short · -0.8% vs prior

Institutional Consensus · 2026-03-31

Held by elite portfolio managers

2 holders · $8.06M

Duquesne Family OfficePoint72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-24	Kestenberg-Messina Kaitlin M.	officer	F	3,177	$8.37	$27K

Other 13D/G Filings on ADMA BIOLOGICS, INC.

Filed	Form	Filer	Stake	Shares
2026-08-07	SCHEDULE 13G	STATE STREET CORP	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →